Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.68 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.64 |
| ▸ | MAOB | P27338 | 4/20 | 0.64 |
| ▸ | MAOA | P21397 | 3/20 | 0.64 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.48 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.47 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6168990 | 1.00 | SCN3A (0.68) | SCN3ASPHK1MAOBMAOAPARP10 | |
| SCHEMBL6168080 | 0.84 | SPHK1 (0.68) | SCN3ASPHK1MAOBMAOANPC1 | |
| SCHEMBL6168088 | 0.84 | SPHK1 (0.68) | SCN3ASPHK1MAOBMAOANPC1 | |
| SCHEMBL6169659 | 0.82 | MAOB (0.68) | SCN3ASPHK1MAOBMAOANPC1 | |
| SCHEMBL6169668 | 0.82 | MAOB (0.68) | SCN3ASPHK1MAOBMAOANPC1 | |
| SCHEMBL6167507 | 0.79 | MAOB (0.79) | SCN3ASPHK1MAOBMAOASPHK2 | |
| SCHEMBL6167500 | 0.79 | MAOB (0.79) | SCN3ASPHK1MAOBMAOASPHK2 | |
| SCHEMBL6170791 | 0.78 | MAOB (0.72) | SCN3ASPHK1MAOBMAOA | |
| SCHEMBL6170788 | 0.78 | MAOB (0.72) | SCN3ASPHK1MAOBMAOA | |
| SCHEMBL6168433 | 0.78 | MAOB (1.00) | SCN3ASPHK1MAOBMAOASPHK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005040108-A1 | PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-05-06 | — | — | WO | claimed |
| EP-1524265-A1 | Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors | Newron Pharmaceuticals S.p.A. (IT) | 2005-04-20 | — | — | EP | claimed |
| WO-2005040108-A1 | PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-05-06 | — | — | WO | disclosed |
| EP-1524265-A1 | Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors | Newron Pharmaceuticals S.p.A. (IT) | 2005-04-20 | — | — | EP | disclosed |